Date: 2015-10-19
Type of information: Collaboration agreement
Compound: Sanger Institute's arrayed lentiviral CRISPR library
Company: Sigma-Aldrich (USA - MO) Wellcome Trust Sanger Institute (UK)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On October 19, 2015, Sigma-Aldrich announced it has entered into an exclusive agreement with the Wellcome Trust Sanger Institute to manufacture and distribute the Sanger Institute's arrayed lentiviral CRISPR library. The library will be the first of its kind, providing researchers with a collection of individual clones designed to knock out every known human and mouse protein-coding gene using the CRISPR system.
Sigma-Aldrich plans to launch the glycerol and lentiviral versions of the Sanger Institute human CRISPR library in 2015. Preorders are being accepted for all versions of the library with priority given to members of Sigma-Aldrich's CRISPR Core lab partnership. The addition of the Sanger CRISPR collection to its portfolio continues Sigma-Aldrich's history of making and supporting lentiviral screening libraries.
Financial terms:
Latest news:
